Section Arrow
INSP.NYSE
- Inspire Medical Systems
Quotes are at least 15-min delayed:2026/03/12 06:32 EDT
Pre Market
Last
 59.7
-0.27 (-0.45%)
Bid
--
Ask
71
High 60 
Low 59.7 
Volume 20 
Regular Hours (Closed)
Last
 59.97
+0.53 (+0.89%)
Day High 
60.925 
Prev. Close
59.44 
1-M High
86 
Volume 
615.72K 
Bid
--
Ask
71
Day Low
58.4 
Open
60.29 
1-M Low
53.11 
Market Cap 
1.70B 
Currency 美元 
P/E 12.23 
%Yield -- 
10-SMA 63.35 
20-SMA 62.34 
50-SMA 76.61 
52-W High 172.95 
52-W Low 53.11 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.89/2.18
Enterprise Value
1.73B
Balance Sheet
Book Value Per Share
27.32
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
911.98M
Operating Revenue Per Share
19.94
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
Pre Market 69.53 -0.1 -0.14%
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
Pre Market 109.99 -0.26 -0.24%
MDTMedtronic plc88.97-0.92-1.02%25.14PE
Pre Market 88.95 -0.02 -0.02%
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
Pre Market 1.36 +0.01 +0.74%
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.